Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives
2025 · Current Opinion in Oncology · 3 citations
https://doi.org/10.1097/cco.0000000000001183
G
Gabriella Gentile
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
54
Papers
777
Citations
14
h-index
22
i10-index
Gabriella Gentile is an academic researcher from Université Libre de Bruxelles. The author has contributed to research in topics: Receptor Mechanisms and Signaling & Neuroscience and Neuropharmacology Research & Stress Responses and Cortisol. The author has an h-index of 14, co-authored 46 publications.
ORCID: 0009-0008-2714-2769Papers by this author
worksManaging relapses during or after adjuvant CDK4/6 inhibitors in HR-positive/HER2-negative early breast cancer: an emerging challenge
2025 · ESMO Open · 2 citations
https://doi.org/10.1016/j.esmoop.2025.105758
The efficacy of preoperative low-residue diet on postoperative ileus following cesarean section
2023 · The Journal of Maternal-Fetal & Neonatal Medicine · 0 citations
https://doi.org/10.1080/14767058.2023.2203795
Co-Occurrence of ALK rearrangement and KRAS G12C mutation in NSCLC: Report of two cases
2024 · Current Problems in Cancer Case Reports · 0 citations
https://doi.org/10.1016/j.cpccr.2024.100291
Beyond the BRCA1/2 genes in ovarian cancer: the role of germline pathogenic variants in the ATM gene
2025 · Molecular Biology Reports · 0 citations
https://doi.org/10.1007/s11033-025-10357-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat